Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438711 · ClinicalTrials.gov registry record
Surgical Decision Making Among People With Inflammatory Bowel Disease
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 91
- Enrollment target
NCT00438711: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00438711 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438711 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
This is a study for people with inflammatory bowel disease ("IBD"--that is, ulcerative colitis, Crohn's colitis, or indeterminate colitis). We are studying how people with IBD decide to have surgery when a doctor has told them they should think about having their colon (large bowel) removed. This surgery is called a "colectomy." Patients will be asked to fill out a questionnaire that takes about 60 to 90 minutes to complete. Questions ask about patients' background (age, etc.) and their IBD. They also ask about patients' decision to have surgery or not to have surgery. For instance, what kinds of things did they think about? Some questions ask about other people who affected the choice and how patients felt about the help they got from others. People who wish to join the study will receive payment to thank them for their time. * Patients must be at least 18 years old * Patients must speak English * Patients must have been told by their doctor to think about having surgery to take out their colon to (a) lower their risk for cancer or (b) because they have pre-cancer (called "dysplasia") * Patients do not need to have had the surgery--they may have already had the surgery, they may not have had it yet, or they may have decided they do not want to have it
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-12 |
What the finished NCT00438711 record still lists
NCT00438711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00438711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00438711 about?
NCT00438711 is a clinical study titled "Surgical Decision Making Among People With Inflammatory Bowel Disease". This is a study for people with inflammatory bowel disease ("IBD"--that is, ulcerative colitis, Crohn's colitis, or indeterminate colitis). We are studying how people with IBD decide to have surgery when a doctor has told them they should think about having their colon (large bowel) removed. This su...
What is the current status of trial NCT00438711?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2005-09. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00438711?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia